| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.57 | 0.03 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.37 | 0.01 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.24 | 1e-05 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-07 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0006 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.007 |